GreenLight Biosciences Holdings (GRNA) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.
The consensus price target is $11.00 (low: $4.00, high: $18.00), representing an upside of 3572.8% from the current price $0.30.
GRNA Stock — 12-Month Price Forecast
$11.00
▲ +3,572.79% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for GreenLight Biosciences Holdings, the average price target is $11.00, with a high forecast of $18.00, and a low forecast of $4.00.
The average price target represents a +3,572.79% change from the last price of $0.30.
Highest Price Target
$18.00
Average Price Target
$11.00
Lowest Price Target
$4.00
GRNA Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to GreenLight Biosciences Holdings in the past 3 months
